An approach to the validation of biomarkers of harm for use in a tobacco context

被引：14

作者：

Gregg, EO

Fisher, AL

Lowe, F

McEwan, M

Massey, ED

机构：

[1] ENI Ltd, Pattishall NN12 8JN, Northants, England

[2] British Amer Tobacco Grp R&D, Southampton SO15 8TL, Hants, England

来源：

REGULATORY TOXICOLOGY AND PHARMACOLOGY | 2006年 / 44卷 / 03期

关键词：

biomarkers; pathologic change; validation; epidemiology; tobacco;

D O I：

10.1016/j.yrtph.2005.12.006

中图分类号：

DF [法律]; D9 [法律]; R [医药、卫生];

学科分类号：

0301 ; 10 ;

摘要：

There is both a call and a need for biomarkers of harm that are validated for use in a tobacco context. Currently, there are no validated biomarkers and there is no consensus about which ones may be suitable for this purpose. To advance the science in this area a working definition of biomarkers of harm and a shortlist of candidate biomarkers are proposed. A framework for the validation of bionnarkers of harm using of a series of epidemiological studies culminating in a targeted prospective study is outlined. The candidate biomarkers have advanced to preliminary testing although this does not imply that any on the shortlist will become validated. This framework could also be used for the evaluation of proteomic, genomic, transcriptosomic or metabonomic profiles, which may turn out to be the preferred biomarkers for use in harm prediction. Biomarker studies would complement data that are generated from specific in vitro tests and from animal studies to evaluate tobacco products. (c) 2005 Elsevier Inc. All rights reserved.

引用

页码：262 / 267

页数：6

共 26 条

[1] Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].

Alpert, JS ;

Antman, E ;

Apple, F ;

Armstrong, PW ;

Bassand, JP ;

de Luna, AB ;

Beller, G ;

Breithardt, G ;

Chaitman, BR ;

Clemmensen, P ;

Falk, E ;

Fishbein, MC ;

Galvani, M ;

Garson, A ;

Grines, C ;

Hamm, C ;

Jaffe, A ;

Katus, H ;

Kjekshus, J ;

Klein, W ;

Klootwijk, P ;

Lenfant, C ;

Levy, D ;

Levy, RI ;

Luepker, R ;

Marcus, F ;

Näslund, U ;

Ohman, M ;

Pahlm, O ;

Poole-Wilson, P ;

Popp, R ;

Alto, P ;

Pyörälä, K ;

Ravkilde, J ;

Rehnquist, N ;

Roberts, W ;

Roberts, R ;

Roelandt, J ;

Rydén, L ;

Sans, S ;

Simoons, ML ;

Thygesen, K ;

Tunstall-Pedoe, H ;

Underwood, R ;

Uretsky, BF ;

Van de Werf, F ;

Voipio-Pulkki, LM ;

Wagner, G ;

Wallentin, L ;

Wijns, W .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969

[2] Raised cardiac troponins - Causes extend beyond acute coronary syndromes [J].

Ammann, P ;

Pfisterer, M ;

Fehr, T ;

Rickli, H .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7447) :1028-1029

[3]

[Anonymous], 2004, Beitr. Tabakforsch. Int

[4] Cardiac troponin assays: Analytical issues and clinical reference range cutpoints [J].

Apple F.S. .

Cardiovascular Toxicology, 2001, 1 (2) :93-98

[5] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[6] An overview of the effects of tobacco ingredients on smoke chemistry and toxicity [J].

Baker, RR ;

Massey, ED ;

Smith, G .

FOOD AND CHEMICAL TOXICOLOGY, 2004, 42 :S53-S83

[7] Molecular epidemiology of cancer [J].

Chen, YC ;

Hunter, DJ .

CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :45-54

[8] Troponin testing: an audit in three metropolitan hospitals [J].

Davey, RX .

MEDICAL JOURNAL OF AUSTRALIA, 2003, 179 (02) :81-83

[9] Mortality in relation to smoking: 50 years' observations on male British doctors [J].

Doll, R ;

Peto, R ;

Boreham, J ;

Sutherland, I .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7455) :1519-1528

[10] Oxidative DNA damage: Biological significance and methods of analysis [J].

Guetens, G ;

De Boeck, G ;

Highley, M ;

van Oosterom, AT ;

de Bruijn, EA .

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2002, 39 (4-5) :331-457

← 1 2 3 →